APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepatocyte Growth Factor

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

Selected research

Industry Growth & Trends

Global Hepatocyte Growth Factor Industry Growth and Trends Forecast to 2032

26 December 202592 pages

Choose your research edition.

Industry ResearchHepatocyte Growth Factor Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatocyte Growth Factor Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Hepatocyte Growth Factor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatocyte Growth Factor Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatocyte Growth Factor Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

Asia Pacific will be the largest region of Hepatocyte Growth Factor, which will occupy about 60% market share in 2030. North America will be the second largest market with the consumption market share of 25% in 2030. ViroMed, AnGes MG, M3 Biotechnology, AVEO Pharmaceuticals, Molecular Partners and Yooyoung Pharm are the major manufacturers of industry.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Hepatocyte Growth Factor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hepatocyte Growth Factor market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hepatocyte Growth Factor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hepatocyte Growth Factor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hepatocyte Growth Factor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hepatocyte Growth Factor Market by Company

ViroMed

AnGes MG

M3 Biotechnology

AVEO Pharmaceuticals

Molecular Partners

Yooyoung Pharm

F-star

Galaxy Biotech

Kringle Pharma

Hepatocyte Growth Factor Segment by Type

Phase III (Ongoing)

Phase II (Approved)

Phase II (Ongoing)

Phase 1

Preclinical

Hepatocyte Growth Factor Segment by Application

Oncology

Cardiovascular

Central Nervous System

Hematological Disorders

Others

Hepatocyte Growth Factor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatocyte Growth Factor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatocyte Growth Factor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatocyte Growth Factor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hepatocyte Growth Factor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hepatocyte Growth Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Phase III (Ongoing) Table 2. Major Company of Phase II (Approved) Table 3. Major Company of Phase II (Ongoing) Table 4. Major Company of Phase 1 Table 5. Major Company of Preclinical Table 6. Global Hepatocyte Growth Factor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Hepatocyte Growth Factor Sales by Type (2021-2026) & (K Units) Table 8. Global Hepatocyte Growth Factor Sales Market Share in Volume by Type (2021-2026) Table 9. Global Hepatocyte Growth Factor Sales by Type (2021-2026) & (US$ Million) Table 10. Global Hepatocyte Growth Factor Sales Market Share in Value by Type (2021-2026) Table 11. Global Hepatocyte Growth Factor Price by Type (2021-2026) & (USD/Unit) Table 12. Global Hepatocyte Growth Factor Sales by Type (2027-2032) & (K Units) Table 13. Global Hepatocyte Growth Factor Sales Market Share in Volume by Type (2027-2032) Table 14. Global Hepatocyte Growth Factor Sales by Type (2027-2032) & (US$ Million) Table 15. Global Hepatocyte Growth Factor Sales Market Share in Value by Type (2027-2032) Table 16. Global Hepatocyte Growth Factor Price by Type (2027-2032) & (USD/Unit) Table 17. North America Hepatocyte Growth Factor Sales by Type (2021-2026) & (K Units) Table 18. North America Hepatocyte Growth Factor Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Hepatocyte Growth Factor Sales by Type (2021-2026) & (K Units) Table 20. Europe Hepatocyte Growth Factor Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Hepatocyte Growth Factor Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Hepatocyte Growth Factor Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Hepatocyte Growth Factor Sales by Type (2021-2026) & (K Units) Table 24. Latin America Hepatocyte Growth Factor Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Hepatocyte Growth Factor Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Hepatocyte Growth Factor Sales by Type (2021-2026) & (US$ Million) Table 27. Hepatocyte Growth Factor Industry Trends Table 28. Hepatocyte Growth Factor Industry Drivers Table 29. Hepatocyte Growth Factor Industry Opportunities and Challenges Table 30. Hepatocyte Growth Factor Industry Restraints Table 31. Global Hepatocyte Growth Factor Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Hepatocyte Growth Factor Revenue Market Share by Company (2021-2026) Table 33. Global Hepatocyte Growth Factor Sales by Company (2021-2026) & (K Units) Table 34. Global Hepatocyte Growth Factor Sales Share by Company (2021-2026) Table 35. Global Hepatocyte Growth Factor Market Price by Company (2021-2026) & (USD/Unit) Table 36. Global Hepatocyte Growth Factor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Hepatocyte Growth Factor Major Company Production Sites and Headquarters Table 38. Global Hepatocyte Growth Factor Company, Product Type & Application Table 39. Global Hepatocyte Growth Factor Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Hepatocyte Growth Factor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Hepatocyte Growth Factor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Hepatocyte Growth Factor Sales by Region (2021-2026) & (K Units) Table 44. Global Hepatocyte Growth Factor Sales Market Share in Volume by Region (2021-2026) Table 45. Global Hepatocyte Growth Factor Sales by Region (2021-2026) & (US$ Million) Table 46. Global Hepatocyte Growth Factor Sales Market Share in Value by Region (2021-2026) Table 47. Global Hepatocyte Growth Factor Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 48. Global Hepatocyte Growth Factor Sales by Region (2027-2032) & (K Units) Table 49. Global Hepatocyte Growth Factor Sales Market Share in Volume by Region (2027-2032) Table 50. Global Hepatocyte Growth Factor Sales by Region (2027-2032) & (US$ Million) Table 51. Global Hepatocyte Growth Factor Sales Market Share in Value by Region (2027-2032) Table 52. Global Hepatocyte Growth Factor Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 53. Global Hepatocyte Growth Factor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Hepatocyte Growth Factor Sales by Application (2021-2026) & (K Units) Table 55. Global Hepatocyte Growth Factor Sales Market Share in Volume by Application (2021-2026) Table 56. Global Hepatocyte Growth Factor Sales by Application (2021-2026) & (US$ Million) Table 57. Global Hepatocyte Growth Factor Sales Market Share in Value by Application (2021-2026) Table 58. Global Hepatocyte Growth Factor Price by Application (2021-2026) & (USD/Unit) Table 59. Global Hepatocyte Growth Factor Sales by Application (2027-2032) & (K Units) Table 60. Global Hepatocyte Growth Factor Sales Market Share in Volume by Application (2027-2032) Table 61. Global Hepatocyte Growth Factor Sales by Application (2027-2032) & (US$ Million) Table 62. Global Hepatocyte Growth Factor Sales Market Share in Value by Application (2027-2032) Table 63. Global Hepatocyte Growth Factor Price by Application (2027-2032) & (USD/Unit) Table 64. North America Hepatocyte Growth Factor Sales by Application (2021-2026) & (K Units) Table 65. North America Hepatocyte Growth Factor Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Hepatocyte Growth Factor Sales by Application (2021-2026) & (K Units) Table 67. Europe Hepatocyte Growth Factor Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Hepatocyte Growth Factor Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Hepatocyte Growth Factor Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Hepatocyte Growth Factor Sales by Application (2021-2026) & (K Units) Table 71. Latin America Hepatocyte Growth Factor Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Hepatocyte Growth Factor Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Hepatocyte Growth Factor Sales by Application (2021-2026) & (US$ Million) Table 74. ViroMed Company Information Table 75. ViroMed Business Overview Table 76. ViroMed Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. ViroMed Hepatocyte Growth Factor Product Portfolio Table 78. ViroMed Recent Development Table 79. AnGes MG Company Information Table 80. AnGes MG Business Overview Table 81. AnGes MG Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. AnGes MG Hepatocyte Growth Factor Product Portfolio Table 83. AnGes MG Recent Development Table 84. M3 Biotechnology Company Information Table 85. M3 Biotechnology Business Overview Table 86. M3 Biotechnology Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. M3 Biotechnology Hepatocyte Growth Factor Product Portfolio Table 88. M3 Biotechnology Recent Development Table 89. AVEO Pharmaceuticals Company Information Table 90. AVEO Pharmaceuticals Business Overview Table 91. AVEO Pharmaceuticals Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. AVEO Pharmaceuticals Hepatocyte Growth Factor Product Portfolio Table 93. AVEO Pharmaceuticals Recent Development Table 94. Molecular Partners Company Information Table 95. Molecular Partners Business Overview Table 96. Molecular Partners Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Molecular Partners Hepatocyte Growth Factor Product Portfolio Table 98. Molecular Partners Recent Development Table 99. Yooyoung Pharm Company Information Table 100. Yooyoung Pharm Business Overview Table 101. Yooyoung Pharm Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Yooyoung Pharm Hepatocyte Growth Factor Product Portfolio Table 103. Yooyoung Pharm Recent Development Table 104. F-star Company Information Table 105. F-star Business Overview Table 106. F-star Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. F-star Hepatocyte Growth Factor Product Portfolio Table 108. F-star Recent Development Table 109. Galaxy Biotech Company Information Table 110. Galaxy Biotech Business Overview Table 111. Galaxy Biotech Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. Galaxy Biotech Hepatocyte Growth Factor Product Portfolio Table 113. Galaxy Biotech Recent Development Table 114. Kringle Pharma Company Information Table 115. Kringle Pharma Business Overview Table 116. Kringle Pharma Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. Kringle Pharma Hepatocyte Growth Factor Product Portfolio Table 118. Kringle Pharma Recent Development Table 119. North America Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. North America Hepatocyte Growth Factor Sales by Country (2021-2026) & (K Units) Table 121. North America Hepatocyte Growth Factor Sales Market Share by Country (2021-2026) Table 122. North America Hepatocyte Growth Factor Sales Forecast by Country (2027-2032) & (K Units) Table 123. North America Hepatocyte Growth Factor Sales Market Share Forecast by Country (2027-2032) Table 124. North America Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Hepatocyte Growth Factor Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Hepatocyte Growth Factor Market Share by Country (2021-2026) Table 127. North America Hepatocyte Growth Factor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Hepatocyte Growth Factor Market Share Forecast by Country (2027-2032) Table 129. Europe Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Europe Hepatocyte Growth Factor Sales by Country (2021-2026) & (K Units) Table 131. Europe Hepatocyte Growth Factor Sales Market Share by Country (2021-2026) Table 132. Europe Hepatocyte Growth Factor Sales Forecast by Country (2027-2032) & (K Units) Table 133. Europe Hepatocyte Growth Factor Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Hepatocyte Growth Factor Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Hepatocyte Growth Factor Market Share by Country (2021-2026) Table 137. Europe Hepatocyte Growth Factor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Hepatocyte Growth Factor Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Hepatocyte Growth Factor Sales by Country (2021-2026) & (K Units) Table 141. Asia-Pacific Hepatocyte Growth Factor Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Hepatocyte Growth Factor Sales Forecast by Country (2027-2032) & (K Units) Table 143. Asia-Pacific Hepatocyte Growth Factor Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Hepatocyte Growth Factor Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Hepatocyte Growth Factor Market Share by Country (2021-2026) Table 147. Asia-Pacific Hepatocyte Growth Factor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Hepatocyte Growth Factor Market Share Forecast by Country (2027-2032) Table 149. Latin America Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Latin America Hepatocyte Growth Factor Sales by Country (2021-2026) & (K Units) Table 151. Latin America Hepatocyte Growth Factor Sales Market Share by Country (2021-2026) Table 152. Latin America Hepatocyte Growth Factor Sales Forecast by Country (2027-2032) & (K Units) Table 153. Latin America Hepatocyte Growth Factor Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Hepatocyte Growth Factor Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Hepatocyte Growth Factor Market Share by Country (2021-2026) Table 157. Latin America Hepatocyte Growth Factor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Hepatocyte Growth Factor Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Hepatocyte Growth Factor Sales by Country (2021-2026) & (K Units) Table 161. Middle East and Africa Hepatocyte Growth Factor Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Hepatocyte Growth Factor Sales Forecast by Country (2027-2032) & (K Units) Table 163. Middle East and Africa Hepatocyte Growth Factor Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Hepatocyte Growth Factor Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Hepatocyte Growth Factor Market Share by Country (2021-2026) Table 167. Middle East and Africa Hepatocyte Growth Factor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Hepatocyte Growth Factor Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Hepatocyte Growth Factor Distributors List Table 172. Hepatocyte Growth Factor Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Hepatocyte Growth Factor Image Figure 2. Global Hepatocyte Growth Factor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepatocyte Growth Factor Market Size (2021-2032) & (US$ Million) Figure 4. Global Hepatocyte Growth Factor Sales (2021-2032) & (K Units) Figure 5. Phase III (Ongoing) Image Figure 6. Global Phase III (Ongoing) Sales YoY Growth (2021-2032) & (K Units) Figure 7. Phase II (Approved) Image Figure 8. Global Phase II (Approved) Sales YoY Growth (2021-2032) & (K Units) Figure 9. Phase II (Ongoing) Image Figure 10. Global Phase II (Ongoing) Sales YoY Growth (2021-2032) & (K Units) Figure 11. Phase 1 Image Figure 12. Global Phase 1 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Preclinical Image Figure 14. Global Preclinical Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Hepatocyte Growth Factor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Hepatocyte Growth Factor Market Share by Type 2025 VS 2032 Figure 17. North America Hepatocyte Growth Factor Sales Market Share in Volume by Type in 2025 Figure 18. North America Hepatocyte Growth Factor Sales Market Share in Value by Type in 2025 Figure 19. Europe Hepatocyte Growth Factor Sales Market Share in Volume by Type in 2025 Figure 20. Europe Hepatocyte Growth Factor Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Hepatocyte Growth Factor Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Hepatocyte Growth Factor Sales Market Share in Value by Type in 2025 Figure 23. Latin America Hepatocyte Growth Factor Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Hepatocyte Growth Factor Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Hepatocyte Growth Factor Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Hepatocyte Growth Factor Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Hepatocyte Growth Factor Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Oncology Image Figure 30. Global Oncology Sales YoY Growth (2021-2032) & (K Units) Figure 31. Cardiovascular Image Figure 32. Global Cardiovascular Sales YoY Growth (2021-2032) & (K Units) Figure 33. Central Nervous System Image Figure 34. Global Central Nervous System Sales YoY Growth (2021-2032) & (K Units) Figure 35. Hematological Disorders Image Figure 36. Global Hematological Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Hepatocyte Growth Factor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Hepatocyte Growth Factor Market Share by Application 2025 VS 2032 Figure 41. North America Hepatocyte Growth Factor Sales Market Share in Volume by Application in 2025 Figure 42. North America Hepatocyte Growth Factor Sales Market Share in Value by Application in 2025 Figure 43. Europe Hepatocyte Growth Factor Sales Market Share in Volume by Application in 2025 Figure 44. Europe Hepatocyte Growth Factor Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Hepatocyte Growth Factor Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Hepatocyte Growth Factor Sales Market Share in Value by Application in 2025 Figure 47. Latin America Hepatocyte Growth Factor Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Hepatocyte Growth Factor Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Hepatocyte Growth Factor Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Hepatocyte Growth Factor Sales Market Share in Value by Application in 2025 Figure 51. North America Hepatocyte Growth Factor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Hepatocyte Growth Factor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Hepatocyte Growth Factor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Hepatocyte Growth Factor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Hepatocyte Growth Factor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Hepatocyte Growth Factor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Hepatocyte Growth Factor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Hepatocyte Growth Factor Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Hepatocyte Growth Factor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Hepatocyte Growth Factor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Hepatocyte Growth Factor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Hepatocyte Growth Factor Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Hepatocyte Growth Factor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Hepatocyte Growth Factor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Hepatocyte Growth Factor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Hepatocyte Growth Factor Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Hepatocyte Growth Factor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Hepatocyte Growth Factor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Hepatocyte Growth Factor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Hepatocyte Growth Factor Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Hepatocyte Growth Factor Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Hepatocyte Growth Factor Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Phase III (Ongoing)
  • Phase II (Approved)
  • Phase II (Ongoing)
  • Phase 1
  • Preclinical
Applications
  • Oncology
  • Cardiovascular
  • Central Nervous System
  • Hematological Disorders
  • Others
Companies covered
  • ViroMed
  • AnGes MG
  • M3 Biotechnology
  • AVEO Pharmaceuticals
  • Molecular Partners
  • Yooyoung Pharm
  • F-star
  • Galaxy Biotech
  • Kringle Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hepatocyte Growth Factor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hepatocyte Growth Factor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hepatocyte Growth Factor Market by Type
  6. 1.3.1 Phase III (Ongoing)
  7. 1.3.2 Phase II (Approved)
  8. 1.3.3 Phase II (Ongoing)
  9. 1.3.4 Phase 1
  10. 1.3.5 Preclinical
  11. 1.4 Global Hepatocyte Growth Factor Market Size by Type
  12. 1.4.1 Global Hepatocyte Growth Factor Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Hepatocyte Growth Factor Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Hepatocyte Growth Factor Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Hepatocyte Growth Factor Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Hepatocyte Growth Factor Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Hepatocyte Growth Factor Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Hepatocyte Growth Factor Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Hepatocyte Growth Factor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hepatocyte Growth Factor Industry Trends
  2. 2.2 Hepatocyte Growth Factor Industry Drivers
  3. 2.3 Hepatocyte Growth Factor Industry Opportunities and Challenges
  4. 2.4 Hepatocyte Growth Factor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hepatocyte Growth Factor Revenue (2021-2026)
  2. 3.2 Global Top Players by Hepatocyte Growth Factor Sales (2021-2026)
  3. 3.3 Global Top Players by Hepatocyte Growth Factor Price (2021-2026)
  4. 3.4 Global Hepatocyte Growth Factor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hepatocyte Growth Factor Major Company Production Sites & Headquarters
  6. 3.6 Global Hepatocyte Growth Factor Company, Product Type & Application
  7. 3.7 Global Hepatocyte Growth Factor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hepatocyte Growth Factor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hepatocyte Growth Factor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hepatocyte Growth Factor Tier 1, Tier 2, and Tier 3
4 Hepatocyte Growth Factor Regional Status and Outlook
  1. 4.1 Global Hepatocyte Growth Factor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hepatocyte Growth Factor Historic Market Size by Region
  3. 4.2.1 Global Hepatocyte Growth Factor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hepatocyte Growth Factor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hepatocyte Growth Factor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hepatocyte Growth Factor Forecasted Market Size by Region
  7. 4.3.1 Global Hepatocyte Growth Factor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hepatocyte Growth Factor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hepatocyte Growth Factor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hepatocyte Growth Factor by Application
  1. 5.1 Hepatocyte Growth Factor Market by Application
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiovascular
  4. 5.1.3 Central Nervous System
  5. 5.1.4 Hematological Disorders
  6. 5.1.5 Others
  7. 5.2 Global Hepatocyte Growth Factor Market Size by Application
  8. 5.2.1 Global Hepatocyte Growth Factor Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Hepatocyte Growth Factor Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Hepatocyte Growth Factor Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Hepatocyte Growth Factor Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Hepatocyte Growth Factor Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Hepatocyte Growth Factor Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Hepatocyte Growth Factor Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Hepatocyte Growth Factor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ViroMed
  2. 6.1.1 ViroMed Company Information
  3. 6.1.2 ViroMed Business Overview
  4. 6.1.3 ViroMed Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ViroMed Hepatocyte Growth Factor Product Portfolio
  6. 6.1.5 ViroMed Recent Developments
  7. 6.2 AnGes MG
  8. 6.2.1 AnGes MG Company Information
  9. 6.2.2 AnGes MG Business Overview
  10. 6.2.3 AnGes MG Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AnGes MG Hepatocyte Growth Factor Product Portfolio
  12. 6.2.5 AnGes MG Recent Developments
  13. 6.3 M3 Biotechnology
  14. 6.3.1 M3 Biotechnology Company Information
  15. 6.3.2 M3 Biotechnology Business Overview
  16. 6.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 M3 Biotechnology Hepatocyte Growth Factor Product Portfolio
  18. 6.3.5 M3 Biotechnology Recent Developments
  19. 6.4 AVEO Pharmaceuticals
  20. 6.4.1 AVEO Pharmaceuticals Company Information
  21. 6.4.2 AVEO Pharmaceuticals Business Overview
  22. 6.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AVEO Pharmaceuticals Hepatocyte Growth Factor Product Portfolio
  24. 6.4.5 AVEO Pharmaceuticals Recent Developments
  25. 6.5 Molecular Partners
  26. 6.5.1 Molecular Partners Company Information
  27. 6.5.2 Molecular Partners Business Overview
  28. 6.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Molecular Partners Hepatocyte Growth Factor Product Portfolio
  30. 6.5.5 Molecular Partners Recent Developments
  31. 6.6 Yooyoung Pharm
  32. 6.6.1 Yooyoung Pharm Company Information
  33. 6.6.2 Yooyoung Pharm Business Overview
  34. 6.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Yooyoung Pharm Hepatocyte Growth Factor Product Portfolio
  36. 6.6.5 Yooyoung Pharm Recent Developments
  37. 6.7 F-star
  38. 6.7.1 F-star Company Information
  39. 6.7.2 F-star Business Overview
  40. 6.7.3 F-star Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 F-star Hepatocyte Growth Factor Product Portfolio
  42. 6.7.5 F-star Recent Developments
  43. 6.8 Galaxy Biotech
  44. 6.8.1 Galaxy Biotech Company Information
  45. 6.8.2 Galaxy Biotech Business Overview
  46. 6.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Galaxy Biotech Hepatocyte Growth Factor Product Portfolio
  48. 6.8.5 Galaxy Biotech Recent Developments
  49. 6.9 Kringle Pharma
  50. 6.9.1 Kringle Pharma Company Information
  51. 6.9.2 Kringle Pharma Business Overview
  52. 6.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Kringle Pharma Hepatocyte Growth Factor Product Portfolio
  54. 6.9.5 Kringle Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Hepatocyte Growth Factor Sales by Country
  2. 7.1.1 North America Hepatocyte Growth Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hepatocyte Growth Factor Sales by Country (2021-2026)
  4. 7.1.3 North America Hepatocyte Growth Factor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hepatocyte Growth Factor Market Size by Country
  6. 7.2.1 North America Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hepatocyte Growth Factor Market Size by Country (2021-2026)
  8. 7.2.3 North America Hepatocyte Growth Factor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hepatocyte Growth Factor Sales by Country
  2. 8.1.1 Europe Hepatocyte Growth Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hepatocyte Growth Factor Sales by Country (2021-2026)
  4. 8.1.3 Europe Hepatocyte Growth Factor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hepatocyte Growth Factor Market Size by Country
  6. 8.2.1 Europe Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hepatocyte Growth Factor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hepatocyte Growth Factor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hepatocyte Growth Factor Sales by Country
  2. 9.1.1 Asia-Pacific Hepatocyte Growth Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hepatocyte Growth Factor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hepatocyte Growth Factor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hepatocyte Growth Factor Market Size by Country
  6. 9.2.1 Asia-Pacific Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hepatocyte Growth Factor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hepatocyte Growth Factor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hepatocyte Growth Factor Sales by Country
  2. 10.1.1 South America Hepatocyte Growth Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hepatocyte Growth Factor Sales by Country (2021-2026)
  4. 10.1.3 South America Hepatocyte Growth Factor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hepatocyte Growth Factor Market Size by Country
  6. 10.2.1 South America Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hepatocyte Growth Factor Market Size by Country (2021-2026)
  8. 10.2.3 South America Hepatocyte Growth Factor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hepatocyte Growth Factor Sales by Country
  2. 11.1.1 Middle East and Africa Hepatocyte Growth Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hepatocyte Growth Factor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hepatocyte Growth Factor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hepatocyte Growth Factor Market Size by Country
  6. 11.2.1 Middle East and Africa Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hepatocyte Growth Factor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hepatocyte Growth Factor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hepatocyte Growth Factor Value Chain Analysis
  2. 12.1.1 Hepatocyte Growth Factor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hepatocyte Growth Factor Production Mode & Process
  7. 12.2 Hepatocyte Growth Factor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hepatocyte Growth Factor Distributors
  10. 12.2.3 Hepatocyte Growth Factor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst